These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 19615673

  • 1. Cytotoxic T cell immunity against the non-immunogenic, murine, hepatocellular carcinoma Hepa1-6 is directed towards the novel alternative form of macrophage colony stimulating factor.
    Ge L, Zhang JG, Samathanam CA, Delgado C, Tarbiyat-Boldaji M, Dan Q, Hoa N, Nguyen TV, Alipanah R, Pham JT, Sanchez R, Wepsic HT, Morgan TR, Jadus MR.
    Cell Immunol; 2009; 259(2):117-27. PubMed ID: 19615673
    [Abstract] [Full Text] [Related]

  • 2. Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor.
    Dan Q, Sanchez R, Delgado C, Wepsic HT, Morgan K, Chen Y, Jeffes EW, Lowell CA, Morgan TR, Jadus MR.
    Mol Ther; 2001 Nov; 4(5):427-37. PubMed ID: 11708879
    [Abstract] [Full Text] [Related]

  • 3. Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma.
    Peng B, Liang L, Chen Z, He Q, Kuang M, Zhou F, Lu M, Huang J.
    Hepatogastroenterology; 2006 Nov; 53(69):409-14. PubMed ID: 16795983
    [Abstract] [Full Text] [Related]

  • 4. [Inhibitory effects of human AFP-derived peptide-pulsed dendritic cells on mouse hepatocellular carcinoma].
    Pang XH, Chen MS, Jia WH, Zhou XX.
    Ai Zheng; 2008 Dec; 27(12):1233-8. PubMed ID: 19079985
    [Abstract] [Full Text] [Related]

  • 5. [Effect of tumor antigen specific CTL induced by dendritic cells on a model of human hepatocellular carcinoma in nude mice (LCI-D20)].
    Chen GL, Hu HD, Ma YJ, Li YG, Xue Q, Chen M, Ren H.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jun; 14(6):431-4. PubMed ID: 16792867
    [Abstract] [Full Text] [Related]

  • 6. [Antitumor immune responses induced by gene transfer of 4-1BBL into hepatocellular carcinoma Hepa1-6 in vitro].
    Liu CL, Dou KF, Zang XX, Zhu BF, Chen SM.
    Zhonghua Wai Ke Za Zhi; 2004 May 07; 42(9):554-8. PubMed ID: 15196371
    [Abstract] [Full Text] [Related]

  • 7. Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12.
    Tamaki S, Homma S, Enomoto Y, Komita H, Zeniya M, Ohno T, Toda G.
    Clin Immunol; 2005 Dec 07; 117(3):280-93. PubMed ID: 16246626
    [Abstract] [Full Text] [Related]

  • 8. Growth suppression of the hepatocellular carcinoma cell line Hepa1-6 by an activatable interferon regulatory factor-1 in mice.
    Kröger A, Ortmann D, Krohne TU, Mohr L, Blum HE, Hauser H, Geissler M.
    Cancer Res; 2001 Mar 15; 61(6):2609-17. PubMed ID: 11289138
    [Abstract] [Full Text] [Related]

  • 9. Membrane macrophage colony-stimulating factor on MADB106 breast cancer cells does not activate cytotoxic macrophages but immunizes rats against breast cancer.
    Williams CC, Trinh H, Tran TV, Dan Q, Sanchez R, Delgado C, Chen Y, Sippel B, Jeffes EW, Wepsic HT, Jadus MR.
    Mol Ther; 2001 Feb 15; 3(2):216-24. PubMed ID: 11237678
    [Abstract] [Full Text] [Related]

  • 10. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Nakamori M, Ueda K, Naka T, Katsuda M, Miyazawa M, Yamaue H.
    Int J Oncol; 2007 Oct 15; 31(4):931-9. PubMed ID: 17786327
    [Abstract] [Full Text] [Related]

  • 11. Development of systemic immunity to glioblastoma multiforme using tumor cells genetically engineered to express the membrane-associated isoform of macrophage colony-stimulating factor.
    Graf MR, Jadus MR, Hiserodt JC, Wepsic HT, Granger GA.
    J Immunol; 1999 Nov 15; 163(10):5544-51. PubMed ID: 10553082
    [Abstract] [Full Text] [Related]

  • 12. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2.
    Mochimaru H, Nagai N, Hasegawa G, Kudo-Saito C, Yaguchi T, Usui Y, Kurihara T, Koto T, Satofuka S, Shinoda H, Ozawa Y, Tsubota K, Kawakami Y, Ishida S.
    Invest Ophthalmol Vis Sci; 2007 Oct 15; 48(10):4795-801. PubMed ID: 17898306
    [Abstract] [Full Text] [Related]

  • 13. Induction of cytotoxic T lymphocytes by dendritic cells pulsed with murine leukemic cell RNA.
    Jung CW, Kwon JH, Seol JG, Park WH, Hyun JM, Kim ES, Kim ST, Lee SJ, Kim BK, Lee YY.
    Am J Hematol; 2004 Mar 15; 75(3):121-7. PubMed ID: 14978690
    [Abstract] [Full Text] [Related]

  • 14. Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice.
    Nakatsura T, Komori H, Kubo T, Yoshitake Y, Senju S, Katagiri T, Furukawa Y, Ogawa M, Nakamura Y, Nishimura Y.
    Clin Cancer Res; 2004 Dec 15; 10(24):8630-40. PubMed ID: 15623647
    [Abstract] [Full Text] [Related]

  • 15. [Synergic effect of adenoviral vector-encoding human alpha-fetoprotein and interferon-gamma on immunity against hepatocellular carcinoma in mice].
    Tan XH, Zhu Q.
    Ai Zheng; 2008 Feb 15; 27(2):155-9. PubMed ID: 18279612
    [Abstract] [Full Text] [Related]

  • 16. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2.
    Mochimaru H, Usui T, Yaguchi T, Nagahama Y, Hasegawa G, Usui Y, Shimmura S, Tsubota K, Amano S, Kawakami Y, Ishida S.
    Invest Ophthalmol Vis Sci; 2008 May 15; 49(5):2172-7. PubMed ID: 18263815
    [Abstract] [Full Text] [Related]

  • 17. [Cloning, expression and antitumor effect of mouse costimulatory molecule 4-1BBL].
    Liu CL, Dou KF, Zhu BF, Zang XX, Chai YB, Du KJ, Chen SM.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan 15; 20(1):118-22. PubMed ID: 15182637
    [Abstract] [Full Text] [Related]

  • 18. Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
    Li B, VanRoey M, Wang C, Chen TH, Korman A, Jooss K.
    Clin Cancer Res; 2009 Mar 01; 15(5):1623-34. PubMed ID: 19208793
    [Abstract] [Full Text] [Related]

  • 19. Gene therapy by membrane-expressed superantigen for alpha-fetoprotein-producing hepatocellular carcinoma.
    Si S, Sun Y, Li Z, Ge W, Zhang X, Hu P, Huang Y, Chen G, Song H, Huang Y, Ma B, Li X, Sui Y.
    Gene Ther; 2006 Nov 01; 13(22):1603-10. PubMed ID: 16855617
    [Abstract] [Full Text] [Related]

  • 20. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
    Driessens G, Hoffmann P, Pouwels M, Zlotta A, Schulman C, Velu T, Bruyns CA.
    J Immunother; 2009 Nov 01; 32(2):140-4. PubMed ID: 19238012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.